ClinVar Miner

Submissions for variant NM_000500.7(CYP21A2):c.[710T>A;713T>A;719T>A]

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002298450 SCV002598644 pathogenic Congenital adrenal hyperplasia 2022-09-30 criteria provided, single submitter clinical testing Variant summary: CYP21A2 c.[710T>A;713T>A;719T>A] (p.[Ile237Asn;Val238Glu;Met240Lys]) variant is a complex allele and involves the alteration of multiple nucleotides. The allele frequency of this complex variant could not be determined from population databases such as gnomAD, because the individual variants of the complex have variable frequencies and the exact number of alleles representing a combination of the three in cis is unknown. However, based on the frequency of the least prevalent alleles, namely c.710T>A and c.713T>A, it can be estimated that the complex variant allele will be found at a frequency not to exceed 1.3e-05 in 150898 control chromosomes (gnomAD v3.1.2). This cluster of 3 variants, c.[710T>A;713T>A;719T>A], is assumed to be transferred together from the CYP21A1P pseudogene to CYP21A2 in a continuous stretch of DNA (Robins_2005), and has been reported in the literature in multiple individuals affected with Congenital Adrenal Hyperplasia (e.g. Higashi_1991, Barbat_1995, Chang_2011, New_2013, Kirac_2014, Essawi_2020, Wang_2021). These data indicate that the variant is very likely to be associated with disease. Experimental evidence evaluating an impact on protein function demonstrated this complex variant has no detectable enzymatic activity (Tusie-Luna_1990, Higashi_1991, Felix-Lopez_2003, Robins_2005). The variant, described as c.710_719delinsACGAGGAGAA, is cited in ClinVar by two submitters (evaluation after 2014) as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
OMIM RCV000012947 SCV000033191 pathogenic Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency 2005-04-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.